Torrent Pharmaceuticals

3,368.00
+33.90
(1.02%)
ann
There are 2 new updates from the company1 day ago
Viewcross
right
Market Cap
1,13,988.40 Cr
EPS
56.47
PE Ratio
59.12
Dividend Yield
0.95 %
Industry
Healthcare
52 Week High
3,590.70
52 Week Low
2,799.85
PB Ratio
15.02
Debt to Equity
0.72
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from27 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+62.96 %
+62.96 %
Hold
Hold+22.22 %
+22.22 %
Sell
Sell+14.81 %
+14.81 %

Company News

View All News
Caret
positive
Torrent Pharma signs agreement to acquire 2.41% additional stake in JB Chemicals for ₹620 crore at ₹1,600 per share. This follows a recent deal to buy 46.39% controlling stake for ₹11,917 crore. Post-acquisition, JB Chemicals will merge into Torrent Pharma.
positive
BofA Securities upgrades Torrent Pharma's target price to Rs 3,500 from Rs 3,300, citing potential margin synergies following the JB Pharma acquisition. The deal is expected to boost Torrent's domestic franchise and provide new growth avenues. Analysts project 250-300 basis points of synergies by FY27-28, with improved earnings per share expected in the first year post-merger.
positive
Torrent Pharmaceuticals plans to acquire JB Chemicals and Pharmaceuticals in a ₹19,500 crore deal over 15-18 months. Initial 46.39% stake purchase from promoter, followed by 2.80% from employees, and a mandatory open offer for up to 26% public stake. Post-acquisition, JB Chemicals will merge into Torrent Pharmaceuticals.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,676.30
#1 4,02,200.50
35.07
#1 52,041.20
12.06
#1 10,980
-18.99
48.33
6,906.50
1,83,345.90
83.65
9,360.00
0.89
2,117
23.05
68.54
1,513.30
1,22,230.40
23.76
28,409.50
7.12
5,291
30.28
54.26
3,368.00
#4 1,13,988.40
#9 59.12
#8 11,317.00
#7 11.59
#8 2,054
#6 10.91
62.08
1,307.40
1,09,111.80
#1 19.63
33,741.20
12.36
5,725
21.14
54.13
1,001.00
1,00,724.00
21.57
22,573.80
13.82
3,977
-0.19
69.99
2,439.50
1,00,685.20
50.68
12,207.40
19.57
1,925
-10.91
59.65
1,980.90
90,466.80
27.51
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,735.00
73,809.50
52.20
6,409.15
10.80
1,417
27.83
64.97
1,191.30
69,190.90
20.01
31,378.10
17.55
3,366
-0.50
63.70

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
11.59 %
Net Income Growth
33.02 %
Cash Flow Change
37.92 %
ROE
20.26 %
ROCE
23.16 %
EBITDA Margin (Avg.)
6.33 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,904
9,058
9,702
14,243
14,121
14,010
14,075
13,100
15,012
15,061
14,990
Fixed Assets
2,833
2,859
3,688
7,855
7,748
7,533
7,065
6,423
8,122
8,138
8,085
Current Assets
4,051
4,688
4,880
5,262
5,038
4,979
5,522
5,165
5,314
5,612
5,623
Capital Work in Progress
678
1,042
520
647
617
712
889
630
765
361
367
Investments
298
780
804
492
353
2
181
226
199
173
2,541
Other Assets
4,095
4,378
4,691
5,249
5,403
5,763
5,940
5,821
5,926
6,389
0
Total Liabilities
7,904
9,058
9,702
14,243
14,121
14,010
14,075
13,100
15,012
15,061
14,990
Current Liabilities
2,824
3,286
2,738
5,202
5,165
5,454
4,892
4,415
5,447
5,425
4,717
Non Current Liabilities
2,589
2,278
2,613
4,418
4,231
3,732
3,346
2,732
3,367
2,779
2,682
Total Equity
2,491
3,495
4,351
4,623
4,724
4,823
5,837
5,953
6,198
6,856
7,591
Reserve & Surplus
2,406
3,410
4,266
4,538
4,640
4,739
5,753
5,868
6,029
6,687
7,422
Share Capital
85
85
85
85
85
85
85
85
169
169
169

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-90
438
18
-366
238
73
-89
-174
110
327
Investing Activities
-2,113
-870
-798
-4,677
-246
229
-444
-196
-2,335
-160
Operating Activities
810
2,742
1,009
894
1,798
1,393
2,005
1,803
2,368
3,266
Financing Activities
1,212
-1,435
-193
3,417
-1,314
-1,549
-1,651
-1,781
77
-2,780

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Jul 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
71.25 %
68.31 %
68.31 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.14 %
14.22 %
14.46 %
16.17 %
16.31 %
DIIs
6.53 %
6.71 %
6.76 %
6.78 %
7.52 %
7.82 %
7.76 %
8.89 %
8.87 %
9.00 %
8.31 %
7.16 %
6.44 %
7.26 %
7.27 %
7.08 %
8.35 %
8.35 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.89 %
7.72 %
7.58 %
7.29 %
7.25 %
7.10 %
7.13 %
4.59 %
4.73 %
4.47 %
4.38 %
4.25 %
4.15 %
4.09 %
3.98 %
4.34 %
4.61 %
4.51 %
Others
14.33 %
14.33 %
14.42 %
14.68 %
13.98 %
13.83 %
13.86 %
15.27 %
15.16 %
15.28 %
16.07 %
17.34 %
18.16 %
3.27 %
3.28 %
2.87 %
2.56 %
2.52 %
No of Share Holders
0
72,616
64,525
64,309
67,205
63,229
62,933
64,557
67,866
63,831
61,572
69,612
69,117
71,154
74,765
79,848
85,035
86,005

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 14 14 17 32 35 48 22 28 0.00
Dividend Yield (%) 0.00 2.24 1.44 1.72 2.51 2.51 3.12 0.85 0.87 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Jun 2025 DIVIDEND Dividend
₹ 6.00 /share
20 Jun 2025 3,241.50 3,168.90
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 3,232.20 3,241.50
01 Feb 2025 DIVIDEND Dividend
₹ 26.00 /share
31 Jan 2025 3,248.40 3,207.70
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 3,238.85 3,248.40
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Oct 2024 3,444.15 3,432.85
23 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Jul 2024 2,830.35 3,138.70
21 Jun 2024 DIVIDEND Dividend
₹ 6.00 /share
21 Jun 2024 2,612.55 2,830.55
12 Feb 2024 DIVIDEND Dividend
₹ 22.00 /share
12 Feb 2024 2,524.70 2,620.40
23 Jun 2023 DIVIDEND Dividend
₹ 8.00 /share
23 Jun 2023 1,714.80 1,864.50
03 Feb 2023 DIVIDEND Dividend
₹ 14.00 /share
03 Feb 2023 1,557.50 1,532.20
11 Jul 2022 BONUS Bonus
1:1
08 Jul 2022 1,420.15 1,482.40
06 Jun 2022 DIVIDEND Dividend
₹ 8.00 /share
03 Jun 2022 1,317.40 1,390.68
06 Jun 2022 DIVIDEND Dividend
₹ 15.00 /share
03 Jun 2022 1,317.40 1,390.68
03 Feb 2022 DIVIDEND Dividend
₹ 25.00 /share
02 Feb 2022 1,580.50 1,353.68
18 Jun 2021 DIVIDEND Dividend
₹ 15.00 /share
17 Jun 2021 1,361.85 1,449.18
16 Feb 2021 DIVIDEND Dividend
₹ 20.00 /share
15 Feb 2021 1,379.15 1,294.25

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication7 hours ago
Business Responsibility and Sustainability Reporting (BRSR)1 day ago
Reg. 34 (1) Annual Report.1 day ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition2 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Closure of Trading Window5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Announcement under Regulation 30 (LODR)-Acquisition6 days ago
Board Meeting Outcome for Disclosure Pursuant To Regulation 30 Read With Schedule III And Regulation 51 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations).6 days ago
Redemption Of Commercial Paper Issued Under ISIN INE685A141208 days ago
Intimation Regarding Issue Of Commercial Papers9 days ago
Redemption Of Commercial Paper Issued Under ISIN INE685A14138Jun 23, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJun 20, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015May 20, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 20, 2025
Intimation Of Record Date For The Purpose Of Payment Of Final Dividend For FY 2024-25May 20, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsMay 20, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendMay 20, 2025
Corporate Action-Board approves DividendMay 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 20-May-25May 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
Results Q4 And Year Ended 31-03-2025.May 20, 2025
Results Q4 And Year Ended 31-03-2025.May 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The Year Ended On 31-Mar-25May 13, 2025
Announcement under Regulation 30 (LODR)-CessationMay 11, 2025
Closure of Trading WindowMar 28, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesMar 26, 2025
Redemption Of Commercial Paper Issued Under ISIN INE685A14112Mar 26, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesMar 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 24, 2025
Integrated Filing (Financial)Jan 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 24, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendJan 24, 2025

Technical Indicators

RSI(14)
Neutral
62.08
ATR(14)
Less Volatile
78.77
STOCH(9,6)
Neutral
70.49
STOCH RSI(14)
Neutral
62.27
MACD(12,26)
Bullish
16.77
ADX(14)
Weak Trend
22.93
UO(9)
Bearish
55.78
ROC(12)
Uptrend And Accelerating
4.37
WillR(14)
Neutral
-34.66

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Large Cap Fund Direct-Growth
1.10%
1078877
0.90%
0.90%
Nippon India Pharma Fund Direct-Growth
1.15%
-200000
-0.87%
-0.86%
Kotak Arbitrage Fund Direct-Growth
0.38%
-137000
-0.11%
0.04%
Kotak Contra Fund Direct-Growth
0.00%
-117450
-0.96%
-0.96%
Kotak Large Cap Fund Direct-Growth
0.37%
117100
0.37%
0.37%
Kotak Midcap Fund Direct-Growth
0.00%
-85038
-0.06%
-1.12%
Quant Healthcare Fund Direct - Growth
0.00%
-83775
-7.03%
-7.31%
Franklin India Bluechip Fund Direct-Growth
2.93%
83740
0.19%
0.86%
Nippon India Arbitrage Fund Direct-Growth
0.67%
79250
0.14%
0.24%
360 ONE Quant Fund Direct - Growth
1.25%
-36488
-1.91%
-1.98%
LIC MF ELSS Tax Saver Direct - Growth
1.00%
34992
1.00%
1.00%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
5.47%
-19643
-1.02%
-1.58%
Invesco India Arbitrage Fund Direct-Growth
0.24%
16250
-0.01%
0.01%
Axis Multi Asset Allocation Direct Plan -Growth
0.34%
15341
0.34%
0.34%
Edelweiss Arbitrage Fund Direct-Growth
0.29%
-12000
-0.06%
-0.05%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.05%
9750
0.01%
0.05%
Mirae Asset Healthcare Fund Direct - Growth
2.91%
9659
-0.02%
-0.06%
UTI Arbitrage Fund Direct-Growth
0.31%
8750
0.01%
0.09%
JM Large Cap Fund Direct Plan-Growth
1.75%
8000
0.37%
0.37%
Aditya Birla Sun Life Arbitrage Fund Direct-Growth
0.26%
8000
-0.03%
-0.06%
LIC MF Multi Cap Fund Direct - Growth
1.01%
7116
0.02%
0.06%
Bandhan Nifty100 Low Volatility 30 Index Fund Direct-Growth
2.82%
6272
-0.16%
-0.18%
UTI Nifty200 Momentum 30 Index Fund Direct - Growth
1.42%
6125
-0.13%
-0.15%
WhiteOak Capital Large Cap Fund Direct - Growth
1.48%
5734
0.06%
-0.07%
SBI Arbitrage Opportunities Fund Direct-Growth
0.19%
5250
-0.01%
-0.01%

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global presence. It specializes in cardiovascular, central nervous system, vitamins and nutrients, gastro-intestinal, and anti-diabetes therapies. The company operates through wholly-owned subsidiaries in over 40 countries, with major operations in the US, Germany, and Brazil. Torrent Pharmaceuticals has manufacturing facilities in multiple Indian states and an R&D center in Ahmedabad. Founded in 1959, the company has grown through acquisitions, expansions, and product launches. It has entered various therapeutic segments including dermatology, gynecology, and oncology. Torrent Pharmaceuticals is engaged in research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations both domestically and internationally.
Chairperson NameSudhir Mehta